Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24-week, Randomized, Open-label, Parallel Group, Multicenter Comparison of Lantus® (Insulin Glargine) Given Once Daily Versus Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Mellitus Aged at Least 6 Years to Less Than 18 Years

NCT01223131 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01223131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01223131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24-week, Randomized, Open-label, Parallel Group, Multicenter Comparison of Lantus® (Insulin Glargine) Given Once Daily Versus Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Mellitus Aged at Least 6 Years to Less Than 18 Years
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2011
Completion date
March 31, 2014
Enrollment
162 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus